Health in Norway

1,107 indicators covering health for Norway.

IndicatorLatest Year10-yr change Rank
Terrorism deaths by region 0 2021 down 100.0% 58th
Medical doctors 27,455 2023 up 25.5% 63rd
Number of stillbirths 104 2023 down 34.6% 150th
Mean systolic blood pressure 121.5 2015 down 2.9% 124th
UHC Service Coverage sub-index on infectious diseases 98 2023 unchanged 51st
UHC Service Coverage sub-index on service capacity and access 99 2023 unchanged 4th
UHC Service Coverage sub-index on reproductive, maternal, newborn and 91 2023 up 1.1% 5th
UHC Service Coverage Index 89 2023 up 3.5% 3rd
UHC Service Coverage sub-index on noncommunicable diseases 71 2023 up 16.4% 27th
Stillbirth rate 2.02 2023 down 25.8% 187th
Maternal mortality ratio 1.31 per 100,000 live births 2023 down 54.6% 177th
Universal health coverage (UHC) service coverage index, 2025 89 index 2023 up 3.5% 3rd
Hepb3 number unvaccinated 2,202 2023 β€” 141st
Rotavirus vaccines completed dose (RotaC) immunization coverage among 95.0% 2025 β€” 16th
Tb related deaths hiv 2 2023 unchanged 137th
Smoking bans in public places 8 2022 up 100.0% 1st
Current health expenditure (CHE) as percentage of gross domestic 9.4% 2023 up 6.3% 36th
External health expenditure (EXT) as percentage of current health 0.0% 2023 β€” 146th
Domestic general government health expenditure (GGHE-D) as percentage 86.1% 2023 up 1.3% 5th
Out-of-pocket expenditure as percentage of current health expenditure 13.7% 2023 down 6.2% 149th
Domestic general government health expenditure (GGHE-D) as percentage 8.1% 2023 up 7.6% 12th
Domestic general government health expenditure (GGHE-D) as percentage 17.4% 2023 up 1.6% 23rd
Domestic private health expenditure (PVT-D) as percentage of current 13.9% 2023 down 7.2% 176th
Current health expenditure (CHE) per capita in US$ 8,296 2023 down 10.2% 4th
Domestic private health expenditure (PVT-D) per capita in US$ 1,153 2023 down 16.7% 17th
Domestic general government health expenditure (GGHE-D) per capita in 7,144 2023 down 9.1% 3rd
Total healthcare expenditure gdp 9.43 2023 up 6.3% 36th
Health expenditure government expenditure 17.37 2023 up 1.6% 23rd
Mumps - number of reported cases 10 2025 down 94.5% 88th
Incidence of tuberculosis (per 100 000 population) 0.07 2023 down 63.2% 158th
Hib vaccine 97 2024 up 3.2% 29th
Congenital Rubella Syndrome - number of reported cases 0 2025 β€” 16th
External health expenditure (EXT) per capita in US$ 0 2023 β€” 149th
Dentists 4,850 2023 up 9.4% 59th
Nursing and midwifery personnel 88,530 2023 up 1.3% 52nd
Nursing personnel 85,943 2023 up 1.5% 48th
Raised blood pressure (SBP>=140 OR DBP>=90) 21.8 2019 down 22.5% 161st
Raised blood pressure (SBP>=140 OR DBP>=90) 25.62 2019 down 17.6% 137th
Hypertension: diagnosis coverage among adults aged 30-79 with 64.0% 2019 up 9.8% 51st
Hypertension among adults aged 30-79 years, prevalence 30.5 2019 down 13.4% 157th
Hypertension effective treatment coverage (controlled hypertension) 28.6% 2019 up 43.0% 38th
Hypertension: effective treatment coverage (controlled hypertension) 29.5% 2019 up 44.6% 40th
Hypertension treatment coverage among adults aged 30-79 with 49.9% 2019 up 15.5% 67th
Hypertension treatment coverage among adults aged 30-79 with 46.7% 2019 up 13.3% 78th
Hypertension: diagnosis coverage among adults aged 30-79 with 66.9% 2019 up 11.5% 44th
Hypertension among adults aged 30-79 years, prevalence, crude 36.3 2019 down 7.2% 101st
Pneumococcal conjugate second or third-dose vaccines (PCVc) 95.0% 2025 up 2.2% 37th
Adolescent birth rate 0 2022 down 100.0% 147th
Rubella number unvaccinated 2,202 2023 down 48.8% 119th
Treatment success rate: previously treated TB cases 69 2023 down 12.7% 91st
Medical doctors 49.75 2023 up 15.5% 11th
Proportion of births attended by skilled health personnel 99.1% 2024 unchanged 65th
Prevalence of insufficient physical activity among adults aged 18+ 38.1% 2022 up 4.7% 42nd
Prevalence of insufficient physical activity among adults aged 18+ 35.1% 2022 up 3.4% 55th
Nursing and midwifery personnel 160.4 2023 down 6.8% 4th
Estimated number of people (all ages) living with HIV 5,300 2025 up 10.4% 114th
Prevalence of HIV among adults aged 15 to 49 0.1% 2025 unchanged 106th
Immunization measles vs vaccine safety 94 2024 up 2.2% 39th
Share of children vaccinated with mcv2 94 2024 up 2.2% 39th
Cases of paralytic polio from vaccine derived viruses 0 2023 β€” 24th